All lobbying filings

THE NICKLES GROUP, LLC

THE NICKLES GROUP, LLC filed a Q3 report for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) on October 19, 2026, reporting $60,000 in lobbying income.

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Medical technology trade association.

All filings by THE NICKLES GROUP, LLC · Everything ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 10

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare coverage of breakthrough technologies. Issues related to the RAPID coverage pathway. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding and coverage of diabetes technologies. The FY2027 IPPS final rule and issues related to new technology add-on payments.

Trade (domestic/foreign)

Issues related to tariffs. Issues related to the United States Mexico Canada Trade Agreement (USMCA).

Defense

H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair and restrictions on stock buybacks and dividends.

Bills named in this filing 4

S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
H.R. 8800
National Defense Authorization Act for Fiscal Year 2027
S. 4784
National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.